About UCLA Institute of Urologic Oncology
Clinical Trials at UCLA Institute of Urologic Oncology
During the past decade, UCLA Institute of Urologic Oncology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "UCLA Institute of Urologic Oncology"
#1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at UCLA Institute of Urologic Oncology
According to Clinical.Site data, the most researched conditions in "UCLA Institute of Urologic Oncology" are
"Bladder Cancer" (1 trials), "Prostate Cancer Metastatic" (1 trials) and "Urothelial Carcinoma" (1 trials). Many other conditions were trialed in "UCLA Institute of Urologic Oncology" in a lesser frequency.
Clinical Trials Intervention Types at UCLA Institute of Urologic Oncology
Most popular intervention types in "UCLA Institute of Urologic Oncology" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "FOR46" (1 trials), "Nivolumab in combination with Urelumab" (1 trials) and "Nivolumab monotherapy" (1 trials). Other intervention names were less common.
Clinical Trials Genders at UCLA Institute of Urologic Oncology
The vast majority of trials in "UCLA Institute of Urologic Oncology" are
1 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at UCLA Institute of Urologic Oncology
Currently, there are NaN active trials in "UCLA Institute of Urologic Oncology".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in UCLA Institute of Urologic Oncology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in UCLA Institute of Urologic Oncology, 1 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".